Freamine Iii 3% W/ Electrolytes

   
Google
 
Web NewDrugInformation.com

Freamine Iii 3% W/ Electrolytes


Drug - Freamine Iii 3% W/ Electrolytes
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Amino Acids; Magnesium Acetate; Phosphoric Acid; Potassium Chloride; Sodium Acetate; Sodium Chloride
Multiple ingredients are in alphabetical order.

Strength - 3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100ML
The potency of the active ingredient(s), Amino Acids; Magnesium Acetate; Phosphoric Acid; Potassium Chloride; Sodium Acetate; Sodium Chloride. May repeat for multiple part products.

Applicant - B BRAUN
The firm name holding legal responsibility for Freamine Iii 3% W/ Electrolytes. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 016822
The FDA assigned number to Freamine Iii 3% W/ Electrolytes. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Freamine Iii 3% W/ Electrolytes. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Freamine Iii 3% W/ Electrolytes was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Freamine Iii 3% W/ Electrolytes. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Freamine Iii 3% W/ Electrolytes is in. Format is RX, OTC, DISCN.

Applicant Full Name - B Braun Medical Inc
The full name of the firm holding legal responsibility for the new application of Freamine Iii 3% W/ Electrolytes.

Freamine Iii 3% W/ Electrolytes


Travasol 4.25% Sulfite Free W/ Electrolytes In Dextrose 5% In Plastic Container 4.25%;5gm/100ml;51mg/100ml;261mg/100ml;297mg/100ml;77mg/100ml Injectable; Injection
Freamine Iii 8.5% W/ Electrolytes 8.5%;110mg/100ml;230mg/100ml;10mg/100ml;440mg/100ml;690mg/100ml Injectable; Injection
Aminosyn 3.5% M 3.5%;21mg/100ml;40mg/100ml;128mg/100ml;234mg/100ml Injectable; Injection
Aminosyn 3.5% M In Plastic Container 3.5%;21mg/100ml;40mg/100ml;128mg/100ml;234mg/100ml Injectable; Injection
Aminosyn 3.5% M In Plastic Container 3.5%;21mg/100ml;40mg/100ml;128mg/100ml;234mg/100ml Injectable; Injection
Freamine Iii 3% W/ Electrolytes 3%;54mg/100ml;40mg/100ml;150mg/100ml;200mg/100ml;120mg/100ml Injectable; Injection
Travasol 4.25% Sulfite Free W/ Electrolytes In Dextrose 10% In Plastic Container 4.25%;10gm/100ml;51mg/100ml;261mg/100ml;297mg/100ml;77mg/100ml Injectable; Injection
Travasol 4.25% Sulfite Free W/ Electrolytes In Dextrose 15% In Plastic Container 4.25%;15gm/100ml;51mg/100ml;261mg/100ml;297mg/100ml;77mg/100ml Injectable; Injection
Travasol 4.25% Sulfite Free W/ Electrolytes In Dextrose 20% In Plastic Container 4.25%;20gm/100ml;51mg/100ml;261mg/100ml;297mg/100ml;77mg/100ml Injectable; Injection
Travasol 4.25% Sulfite Free W/ Electrolytes In Dextrose 25% In Plastic Container 4.25%;25gm/100ml;51mg/100ml;261mg/100ml;297mg/100ml;77mg/100ml Injectable; Injection

NewDrugInformation